Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05615948
PHASE4

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Sponsor: Theresa Jacob, PhD, MPH

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.

Official title: An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression

Key Details

Gender

All

Age Range

18 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2022-12-06

Completion Date

2024-05-17

Last Updated

2026-04-21

Healthy Volunteers

No

Interventions

DRUG

VTS-K

Proprietary oral formulation of 486mg aspirin and 80mg ketamine

Locations (1)

Maimonides Medical Center

Brooklyn, New York, United States